ENTITY
Roche Holding

Roche Holding (ROG SW)

63
Analysis
Health CareUnited States
Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system. Roche Holding serves customers worldwide.
more
Refresh
bullishMorphoSys AG
07 Feb 2024 07:54

Novartis Strikes for Possible Myelofibrosis Blockbuster

​Novartis offers premium for MorphoSys AG in a bet on pelabrisib as a potential blockbuster for myelofibrosis treatment. Shareholders are likely to...

Share
18 Dec 2023 06:44

Liquid Universe of European Ordinary and Preferred Shares: December‘23 Report

Since mid-November, spreads have generally widened across our European liquid universe of ordinary and preferred shares (9 have tightened, 10...

Share
bearishGrifols
18 Mar 2024 06:55

Liquid Universe of European Ordinary and Preferred Shares: March‘24 Report

Since mid-February, spreads have not followed a clear pattern across our European liquid universe of ordinary and preferred shares (9 have...

Share
bullishDaiichi Sankyo
15 Mar 2024 09:30

Daiichi Sankyo (4568 JP): Second Time FY24 Guidance Raise; Event Heavy FY25 With 2 New Drug Approval

​Daiichi Sankyo raised FY24 revenue, core op. profit, and net profit forecast by 2%, 16%, and 30%, respectively. FDA set action dates for HER3-DXd...

Logo
381 Views
Share
bullishPegBio
11 Mar 2024 02:27

PegBio IPO Preview: A Founder-Led Biopharma Player Fighting T2DM and Obesity in China

PegBio, a promising founder-led biotech company, is seeking to tap capital markets in Hong Kong. Their core product for the treatment of T2DM is at...

Logo
285 Views
Share
x